Table 1.
Characteristica | All Subjects (n=66) | IDH (n=35) | No IDH (n=31) |
---|---|---|---|
Age, yr | 58 (49–66) | 54 (43–65) | 61 (53–67) |
Female, % | 30 | 31 | 29 |
Race, % | |||
Asian | 35 | 14 | 58 |
Black | 53 | 69 | 36 |
Other | 1 | 3 | 0 |
White | 11 | 14 | 6 |
Vintage, yr | 2.4 (1.2–5.3) | 2.4 (1.1–5.7) | 2.4 (1.3–5.2) |
Access, % | |||
AV fistula | 69 | 65 | 74 |
AV graft | 26 | 32 | 19 |
Catheter | 5 | 3 | 7 |
Diabetes, % | 64 | 69 | 58 |
Hyperlipidemia, % | 61 | 71 | 48 |
Hypertension, % | 85 | 91 | 77 |
Ischemic heart disease, % | 48 | 40 | 58 |
Heart failure, % | 26 | 34 | 16 |
Coronary artery bypass graft, % | 14 | 9 | 19 |
Arrhythmia, % | 32 | 43 | 19 |
Smoking, % | |||
Current | 8 | 11 | 3 |
Never | 70 | 60 | 81 |
Past | 23 | 29 | 16 |
Weight, kg | 82 (68–95) | 89 (75–120) | 74 (65–90) |
BMI, kg/m2 | 27 (24, 32) | 29 (26, 36) | 26 (22, 28) |
Systolic BP, mm Hg | 141±23 | 143±26 | 138±21 |
LVEF (%) | 55 (55–60) | 57 (55–60) | 55 (50–63) |
Prior myocardial infarction, % | 9 | 9 | 10 |
Beta blocker use, % | 64 | 62 | 67 |
Calcium channel blocker use, % | 60 | 53 | 70 |
Values for continuous variables are given as mean±SD or median (25th–75th percentile). Percentages may not add up to 100 due to rounding. IDH, intradialytic hypotension; AV, arteriovenous; BMI, body mass index; LVEF, left ventricular ejection fraction.
Baseline refers to the average values over the first 2 weeks of the study.